In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million)
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...